Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells
- 1 September 2007
- journal article
- Published by Elsevier in NeuroToxicology
- Vol. 28 (5) , 988-997
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (ES10586, NS38644, NS45133)
This publication has 76 references indexed in Scilit:
- The roles of NADPH oxidase and phospholipases A2in oxidative and inflammatory responses in neurodegenerative diseasesJournal of Neurochemistry, 2007
- Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degenerationNeurobiology of Disease, 2007
- Localizing NADPH Oxidase–Derived ROSScience's STKE, 2006
- Effect of p47phoxgene deletion on ROS production and oxygen sensing in mouse carotid body chemoreceptor cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Molecular pathogenesis of Parkinson's diseaseHuman Molecular Genetics, 2005
- Molecular Pathways of Neurodegeneration in Parkinson's DiseaseScience, 2003
- Role of Proteolytic Activation of Protein Kinase Cδ in Oxidative Stress-Induced ApoptosisAntioxidants & Redox Signaling, 2003
- Parkinson's DiseaseNeuron, 2003
- Critical role of microglial NADPH oxidase‐derived free radicals in the in vitro MPTP model of Parkinson's diseaseThe FASEB Journal, 2003
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003